Status:
RECRUITING
V5/MT Stimulation on Reading and Reading-related Measures in Developmental Dyslexia
Lead Sponsor:
Bambino Gesù Hospital and Research Institute
Conditions:
Developmental Dyslexia
Eligibility:
All Genders
8-13 years
Phase:
NA
Brief Summary
The present study grounds on the absence of evidence-based treatment in individuals with developmental dyslexia (DD). At this topic, the present study will explore the potential effect of transcranial...
Detailed Description
Over the last few decades, a huge number of studies has revealed that Developmental Dyslexia (DD), a brain-based neurodevelopmental disorder characterized by a severe and persistent impairment in the ...
Eligibility Criteria
Inclusion
- Italian speakers right-handed children and adolescents with dyslexia (DSM-5, APA 2013);
- Word/nonword/text reading accuracy and/or speed at least 2 Standard Deviations below the mean for school-age;
- nv IQ ≥ 85;
- normal hearing and normal or corrected-to-normal vision.
Exclusion
- Having a comorbidity with other primary psychiatric/neurological diagnosis (e.g., depression, anxiety, autism, ADHD);
- Having a personal history of neurological/medical/genetic diseases;
- Having ongoing drug treatment influencing brain function;
- Having epilepsy o family history of epilepsy.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05972200
Start Date
September 1 2023
End Date
August 31 2026
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bambino Gesù Hospital and Research Institute
Roma, Italy, 00165